Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 20/20 | 0.64 |
| ▸ | PIK3R1 | P27986 | 17/20 | 0.64 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.62 |
| ▸ | PIK3C2B | O00750 | 1/20 | 0.62 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.62 |
| ▸ | MTOR | P42345 | 1/20 | 0.62 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19611166 | 0.87 | PIK3CA (0.75) | PIK3CAPIK3R1PIK3CDPIK3C2BPIK3CB | |
| SCHEMBL19611242 | 0.86 | PIK3CA (0.63) | PIK3CAPIK3R1PIK3CDPIK3C2BPIK3CB | |
| SCHEMBL19611239 | 0.86 | PIK3CA (0.64) | PIK3CAPIK3R1PIK3CDPIK3C2BPIK3CB | |
| SCHEMBL19611218 | 0.86 | PIK3CA (0.63) | PIK3CAPIK3R1PIK3CDPIK3C2BPIK3CB | |
| SCHEMBL19611293 | 0.85 | PIK3CA (0.64) | PIK3CAPIK3R1PIK3CDPIK3C2BPIK3CB | |
| SCHEMBL19611164 | 0.85 | PIK3CA (0.74) | PIK3CAPIK3R1PIK3CDPIK3C2BPIK3CB | |
| SCHEMBL19611186 | 0.84 | PIK3CA (0.58) | PIK3CAPIK3R1PIK3CDPIK3C2BPIK3CB | |
| SCHEMBL19611252 | 0.84 | PIK3CA (0.58) | PIK3CAPIK3R1PIK3CDPIK3C2BPIK3CB | |
| SCHEMBL19611206 | 0.84 | PIK3CA (0.56) | PIK3CAPIK3R1PIK3CDPIK3C2BPIK3CB | |
| SCHEMBL2378142 | 0.84 | PIK3CA (0.74) | PIK3CAPIK3R1PIK3CDPIK3C2BPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2050749-B1 | PYRIMIDINE DERIVATIVE AS PI3K INHIBITOR AND USE THEREOF | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2017-11-22 | — | — | EP | claimed |